Related Experiment Video
Updated: Nov 15, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.7K
Critical Molecular and Cellular Contributors to Tau Pathology
Liqing Song1, Evan A Wells1, Anne Skaja Robinson1
1Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Biomedicines
|March 6, 2021
Summary
Tauopathies, like Alzheimer's disease, involve toxic tau seed formation and spread. Understanding tau pathology progression and cellular contributors is key to developing new treatments.
Area of Science:
- Neuroscience
- Pathology
Background:
- Tauopathies are neurodegenerative diseases characterized by tau aggregate deposition.
- Pathogenesis involves hyperphosphorylated tau monomers forming toxic seeds.
- Disease spreads via transcellular propagation of tau seeds.
Purpose of the Study:
- To review signaling pathways and cellular contributors to tauopathy progression.
- To provide insights into therapeutic targets for tauopathies.
Main Methods:
- Literature review of tauopathy pathogenesis.
- Analysis of cellular mechanisms and genetic factors.
Main Results:
- Tau seeds form from hyperphosphorylated tau, facilitated by HSP90.
- Glial cells play complex roles, initially protective then contributing to pathology.
- MAPT gene mutations and ApoE ε2 allele are key genetic factors.
Conclusions:
- Dysfunctional neuronal-glial communication exacerbates tauopathy.
- Understanding tau pathology is crucial for developing effective treatments.
Related Concept Videos
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Microtubule Associated Proteins (MAPs)
5.3K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.3K

